{"id":"W2944809072","doi":"10.1016/j.jcjd.2019.04.012","title":"Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sanofi (Canada); LMC Diabetes & Endocrinology (Canada)","funders":"Gilead Sciences; Amgen; Pfizer; Janssen Pharmaceuticals; Juvenile Diabetes Research Foundation Canada; Juvenile Diabetes Research Foundation United States of America; AstraZeneca; Eli Lilly and Company; Novo Nordisk; Sanofi; Merck","keywords":"Medicine; Insulin glargine; Type 2 diabetes; Diabetes mellitus; Insulin; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001613055,0.0004015882,0.0004922271,0.0006425357,0.000631569,0.0008979192,0.0007595475,0.0004359683,0.001085872],"category_scores_gemma":[0.004080313,0.0001879708,0.0007928975,0.002202716,0.0004100791,0.0004527928,0.0006952013,0.0006137538,0.0001516729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005220938,"about_ca_system_score_gemma":0.00447491,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6167124,"about_ca_topic_score_gemma":0.6654062,"domain_scores_codex":[0.9985217,0.0003436265,0.000101246,0.0003590895,0.0003951373,0.0002791022],"domain_scores_gemma":[0.9968822,0.0002804231,0.001669302,0.0002231169,0.0004922391,0.0004526915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008559418,0.00004494005,0.9962403,0.00002167347,0.0002597263,0.00002672863,0.00005682764,0.0001725661,0.00005917886,0.00004343095,0.0006542003,0.001564338],"study_design_scores_gemma":[0.00008731069,0.0001660998,0.9984251,0.00001276851,0.0001328511,0.00006245528,0.0001471131,0.0004326158,0.00002998078,0.00001709463,0.0004715263,0.00001502359],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924614,0.0003137556,0.00006349377,0.0001355115,0.000007836319,0.00002616746,0.006221954,0.000006453158,0.0007634709],"genre_scores_gemma":[0.9930949,0.0001591918,0.0001634238,0.00009208305,0.00001033675,0.00001914816,0.006314509,0.000002778644,0.000143564],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3832876,"threshold_uncertainty_score":0.7710897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01844105004292507,"score_gpt":0.2774945769895215,"score_spread":0.2590535269465964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}